Targeting immunometabolism for the treatment of diabetic cardiomyopathy

IF 10.8 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Nature cardiovascular research Pub Date : 2026-02-23 DOI:10.1038/s44161-025-00771-6

Takuma Takada, Jamie Francisco, Sebastiano Sciarretta, Junichi Sadoshima

引用次数: 0

Abstract

Aberrant immunometabolic signaling promotes cardiac remodeling in type 2 diabetes. Targeting this axis by enhancing the migratory capacity of regulatory T cells improves diabetic cardiomyopathy.

Abstract Image

查看原文本刊更多论文

靶向免疫代谢治疗糖尿病性心肌病

异常免疫代谢信号促进2型糖尿病患者心脏重构通过增强调节性T细胞的迁移能力靶向该轴可改善糖尿病性心肌病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature cardiovascular research

CiteScore

5.70

自引率

0.00%

发文量